Functional analysis of p53 binding under differential stresses

Molecular and Cellular Biology

Volumn 26, Issue 19, 2006, Pages 7030-7045

  Krieg, Adam J ^a   Hammond, Ester M ^a   Giaccia, Amato J ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INHIBITOR; CELL PROTEIN; CYCLINE; CYTOCHROME C OXIDASE; DOXORUBICIN; GLUTATHIONE PEROXIDASE 1; JAGGED1; MYC PROTEIN; PROTEIN JAGGED2; PROTEIN P53; SEC1 FAMILY DOMAIN CONTAINING 2 PROTEIN; SYNOVIAL APOPTOSIS INHIBITOR 1; TORSIN A INTERACTING PROTEIN 1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CPG ISLAND; DNA DAMAGE; GENE INDUCTION; GENE REPRESSION; HUMAN; HUMAN CELL; HYPOXIA; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; STRESS; TRANSCRIPTION REGULATION;

BASE SEQUENCE; CELL HYPOXIA; CHROMATIN IMMUNOPRECIPITATION; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA; DNA DAMAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HCT116 CELLS; HUMANS; KINETICS; MICROARRAY ANALYSIS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-MDM2; REPRODUCIBILITY OF RESULTS; RESPONSE ELEMENTS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33749164424     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00322-06     Document Type: Article

References (87)

1. Adimoolam, S., and J. M. Ford. 2002. p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene. Proc. Natl. Acad. Sci. USA 99:12985-12990.
2. Alarcon, R., C. Koumenis, R. K. Geyer, C. G. Maki, and A. J. Giaccia. 1999. Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation. Cancer Res. 59:6046-6051.
3. Alders, M., A. Ryan, M. Hodges, J. Bliek, A. P. Feinberg, O. Privitera, A. Westerveld, P. F. Little, and M. Mannens. 2000. Disruption of a novel imprinted zinc-finger gene, ZNF215, in Beckwith-Wiedemann syndrome. Am. J. Hum. Genet. 66:1473-1484.
4. Allison, S. J., and J. Milner. 2004. Remodelling chromatin on a global scale: a novel protective function of p53. Carcinogenesis 25:1551-1557.
5. Amundson, S. A., M. Bittner, Y. Chen, J. Trent, P. Meltzer, and A. J. Fornace, Jr. 1999. Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses. Oncogene 18:3666-3672.
6. Antequera, F., and A. Bird. 1993. Number of CpG islands and genes in human and mouse. Proc. Natl. Acad. Sci. USA 90:11995-11999.
7. Brown, J. M., and A. J. Giaccia. 1998. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res. 58:1408-1416.
8. Cartharius, K., K. Frech, K. Grote, B. Klocke, M. Haltmeier, A. Klingenhoff, M. Frisch, M. Bayerlein, and T. Werner. 2005. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21:2933-2942.
9. Cawley, S., S. Bekiranov, H. H. Ng, P. Kapranov, E. A. Sekinger, D. Kampa, A. Piccolboni, V. Sementchenko, J. Cheng, A. J. Williams, R. Wheeler, B. Wong, J. Drenkow, M. Yamanaka, S. Patel, S. Brubaker, H. Tammana, G. Helt, K. Struhl, and T. R. Gingeras. 2004. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116:499-509.
10. Ceribelli, M., M. Alcalay, M. A. Vigano, and R. Mantovani. 2006. Repression of new p53 targets revealed by ChIP on chip experiments. Cell Cycle 5:1102-1110.
11. Craig, J. M., and W. A. Bickmore. 1994. The distribution of CpG islands in mammalian chromosomes. Nat. Genet. 7:376-382.
12. Cross, S. H., V. H. Clark, M. W. Simmen, W. A. Bickmore, H. Maroon, C. F. Langford, N. P. Carter, and A. P. Bird. 2000. CpG island libraries from human chromosomes 18 and 22: landmarks for novel genes. Mamm. Genome 11:373-383.
13. el-Deiry, W. S., S. E. Kern, J. A. Pietenpol, K. W. Kinzler, and B. Vogelstein. 1992. Definition of a consensus binding site for p53. Nat. Genet. 1:45-49.
14. el-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
15. Forsytbe, J. A., B. H. Jiang, N. V. Iyer, F. Agani, S. W. Leung, R. D. Koos, and G. L. Semenza. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16:4604-4613.
16. Gassmann, R., A. Carvalho, A. J. Henzing, S. Ruchaud, D. F. Hudson, R. Honda, E. A. Nigg, D. L. Gerloff, and W. C. Earnshaw. 2004. Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle. J. Cell Biol. 166:179-191.
17. Giaccia, A. J., and M. B. Kastan. 1998. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12:2973-2983.
18. Gibbs, P. E., W. G. McGregor, V. M. Maher, P. Nisson, and C. W. Lawrence. 1998. A human homolog of the Saccharomyces cerevisiae REV3 gene, which encodes the catalytic subunit of DNA polymerase zeta. Proc. Natl. Acad. Sci. USA 95:6876-6880.
19. Graeber, T. G., C. Osmanian, T. Jacks, D. E. Housman, C. J. Koch, S. W. Lowe, and A. J. Giaccia. 1996. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379:88-91.
20. 1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 14:6264-6277.
21. Grandori, C., S. M. Cowley, L. P. James, and R. N. Eisenman. 2000. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16:653-699.
22. Hammond, E. M., D. J. Mandell, A. Salim, A. J. Krieg, T. M. Johnson, H. A. Shirazi, L. D. Attardi, and A. J. Giaccia. 2006. Genome-wide analysis of p53 under hypoxic conditions. Mol. Cell. Biol. 26:3492-3504.
23. Hammond, E. M., N. C. Denko, M. J. Dorie, R. T. Abraham, and A. J. Giaccia. 2002. Hypoxia links ATR and p53 through replication arrest. Mol. Cell. Biol. 22:1834-1843.
24. Hammond, E. M., and A. J. Giaccia. 2005. The role of p53 in hypoxia-induced apoptosis. Biochem. Biophys. Res. Commun. 331:718-725.
25. Hammond, E. M., S. L. Green, and A. J. Giaccia. 2003. Comparison of hypoxia-induced replication arrest with hydroxyurea and aphidicolin-induced arrest. Mutat. Res. 532:205-213.
26. Harms, K., S. Nozell, and X. Chen. 2004. The common and distinct target genes of the p53 family transcription factors. Cell. Mol. Life Sci. 61:822-842.
27. Hearnes, J. M., D. J. Mays, K. L. Schavolt, L. Tang, X. Jiang, and J. A. Pietenpol. 2005. Chromatin immunoprecipitation-based screen to identify functional genomic binding sites for sequence-specific transactivators. Mol. Cell. Biol. 25:10148-10158.
28. Heisler, L. E., D. Torti, P. C. Boutros, J. Watson, C. Chan, N. Winegarden, M. Takahashi, P. Yau, T. H. Huang, P. J. Farnham, I. Jurisica, J. R. Woodgett, R. Bremner, L. Z. Penn, and S. D. Der. 2005. CpG island microarray probe sequences derived from a physical library are representative of CpG islands annotated on the human genome. Nucleic Acids Res. 33:2952-2961.
29. Ho, J., and S. Benchimol. 2003. Transcriptional repression mediated by the p53 tumour suppressor. Cell Death Differ. 10:404-408.
30. 1 cell cycle arrest. Mol. Cell. Biol. 25:7423-7431.
31. Hoffman, W. H., S. Biade, J. T. Zilfou, J. Chen, and M. Murphy. 2002. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J. Biol. Chem. 277:3247-3257.
32. Hwang, B. J., J. M. Ford, P. C. Hanawalt, and G. Chu. 1999. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc. Natl. Acad. Sci. USA 96:424-428.
33. 2/M promoters. Mol. Cell. Biol. 25:3737-3751.
34. Jakacka, M., M. Ito, F. Martinson, T. Ishikawa, E. J. Lee, and J. L. Jameson. 2002. An estrogen receptor (ER) alpha deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Mol. Endocrinol. 16:2188-2201.
35. Jakacka, M., M. Ito, J. Weiss, P. Y. Chien, B. D. Gehm, and J. L. Jameson. 2001. Estrogen receptor binding to DNA is not required for its activity through the nonclassical API pathway. J. Biol. Chem. 276:13615-13621.
36. Jen, K. Y., and V. G. Cheung. 2005. Identification of novel p53 target genes in ionizing radiation response. Cancer Res. 65:7666-7673.
37. Johnson, T. M., E. M. Hammond, A. Giaccia, and L. D. Attardi. 2005. The p53QS transactivation-deficient mutant shows stress-specific apoptotic activity and induces embryonic lethality. Nat. Genet. 37:145-152.
38. Kaneko, M., M. Ishiguro, Y. Niinuma, M. Uesugi, and Y. Nomura. 2002. Human HRD1 protects against ER stress-induced apoptosis through ER-associated degradation. FEBS Lett. 532:147-152.
39. Kikkert, M., R. Doolman, M. Dai, R. Avner, G. Hassink, S. van Voorden, S. Thanedar, J. Roitelman, V. Chau, and E. Wiertz. 2004. Human HRD1 is an E3 ubiquitin ligase involved in degradation of proteins from the endoplasmic reticulum. J. Biol. Chem. 279:3525-3534.
40. Kirmizis, A., S. M. Bartley, A. Kuzmichev, R. Margueron, D. Reinberg, R. Green, and P. J. Farnham. 2004. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. Genes Dev. 18:1592-1605.
41. Kolehmainen, J., G. C. Black, A. Saarinen, K. Chandler, J. Clayton-Smith, A. L. Traskelin, R. Perveen, S. Kivitie-Kallio, R. Norio, M. Warburg, J. P. Fryns, A. de la Chapelle, and A. E. Lehesjoki. 2003. Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport. Am. J. Hum. Genet. 72:1359-1369.
42. Koshiji, M., Y. Kageyama, E. A. Pete, I. Horikawa, J. C. Barrett, and L. E. Huang. 2004. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J. 23:1949-1956.
43. Koumenis, C., R. Alarcon, E. Hammond, P. Sutphin, W. Hoffman, M. Murphy, J. Derr, Y. Taya, S. W. Lowe, M. Kastan, and A. Giaccia. 2001. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol. Cell. Biol. 21:1297-1310.
44. Krieg, A. J., S. A. Krieg, B. S. Ahn, and D. J. Shapiro. 2004. Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes. J. Biol. Chem. 279:5025-5034.
45. Kzhyshkowska, J., A. Rusch, H. Wolf, and T. Dobner. 2003. Regulation of transcription by the heterogeneous nuclear ribonucleoprotein E1B-AP5 is mediated by complex formation with the novel bromodomain-containing protein BRD7. Biochem. J. 371:385-393.
46. Laganiere, J., G. Deblois, C. Lefebvre, A. R. Bataille, F. Robert, and V. Giguere. 2005. From the cover: location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc. Natl. Acad. Sci. USA 102:11651-11656.
47. Lee, S., B. Elenbaas, A. Levine, and J. Griffith. 1995. p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81:1013-1020.
48. Li, Z., H. Zhang, T. P. McManus, J. J. McCormick, C. W. Lawrence, and V. M. Maher. 2002. hREV3 is essential for error-prone translesion synthesis past UV or benzo[a]pyrene diol epoxide-induced DNA lesions in human fibroblasts. Mutat. Res. 510:71-80.
49. Lin, X., K. Ramamurthi, M. Mishima, A. Kondo, R. D. Christen, and S. B. Howell. 2001. p53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin. Cancer Res. 61:1508-1516.
50. Lin, X., J. Trang, T. Okuda, and S. B. Howell. 2006. DNA polymerase zeta accounts for the reduced cytotoxicity and enhanced mutagenicity of cisplatin in human colon carcinoma cells that have lost DNA mismatch repair. Clin. Cancer Res. 12:563-568.
51. Liu, L., and M. C. Simon. 2004. Regulation of transcription and translation by hypoxia. Cancer Biol. Ther. 3:492-497.
52. Lomvardas, S., and D. Thanos. 2002. Modifying gene expression programs by altering core promoter chromatin architecture. Cell 110:261-271.
53. Mao, D. Y., J. D. Watson, P. S. Yan, D. Barsyte-Lovejoy, F. Khosravi, W. W. Wong, P. J. Farnham, T. H. Huang, and L. Z. Penn. 2003. Analysis of Myc bound loci identified by CpG island arrays shows that Max is essential for Myc-dependent repression. Curr. Biol. 13:882-886.
54. Moberg, K. H., W. A. Tyndall, and D. J. Hall. 1992. Wild-type rnurine p53 represses transcription from the murine c-myc promoter in a human glial cell line. J. Cell Biochem. 49:208-215.
55. Montano, M. M., B. M. Wittmann, and N. R. Bianco. 2000. Identification and characterization of a novel factor that regulates quinone reductase gene transcriptional activity. J. Biol. Chem. 275:34306-34313.
56. Murphy, M., J. Ahn, K. K. Walker, W. H. Hoffman, R. M. Evans, A. J. Levine, and D. L. George. 1999. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev. 13:2490-2501.
57. Murphy, M., A. Hinman, and A. J. Levine. 1996. Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes Dev. 10:2971-2980.
58. Nagao, Y., J. S. Platero, A. Waheed, and W. S. Sly. 1993. Human mitochondrial carbonic anhydrase: cDNA cloning, expression, subcellular localization, and mapping to chromosome 16. Proc. Natl. Acad. Sci. USA 90:7623-7627.
59. Nguyen, T. T., K. Cho, S. A. Stratton, and M. C. Barton. 2005. Transcription factor interactions and chromatin modifications associated with p53-mediated, developmental repression of the alpha-fetoprotein gene. Mol. Cell. Biol. 25:2147-2157.
60. Oberley, M. J., D. R. Inman, and P. J. Farnham. 2003. E2F6 negatively regulates BRCA1 in human cancer cells without methylation of histone H3 on lysine 9. J. Biol. Chem. 278:42466-42476.
61. Oberley, M. J., J. Tsao, P. Yau, and P. J. Farnham. 2004. High-throughput screening of chromatin immunoprecipitates using CpG-island microarrays. Methods Enzymol. 376:315-334.
62. Orian, A., B. van Steensel, J. Delrow, H. J. Bussemaker, L. Li, T. Sawado, E. Williams, L. W. Loo, S. M. Cowley, C. Yost, S. Pierce, B. A. Edgar, S. M. Parkhurst, and R. N. Eisenman. 2003. Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev. 17:1101-1114.
63. Osada, M., H. L. Park, Y. Nagakawa, K. Yamashita, A. Fomenkov, M. S. Kim, G. Wu, S. Nomoto, B. Trink, and D. Sidransky. 2005. Differential recognition of response elements determines target gene specificity for p53 and p63. Mol. Cell. Biol. 25:6077-6089.
64. Persengiev, S. P., L. R. Devireddy, and M. R. Green. 2002. Inhibition of apoptosis by ATFx: a novel role for a member of the ATF/CREB family of mammalian bZIP transcription factors. Genes Dev. 16:1806-1814.
65. Prakash, S., R. E. Johnson, and L. Prakash. 2005. Eukaryotic translesion synthesis DNA polymerases: specificity of structure and function. Annu. Rev. Biochem. 74:317-353.
66. Qian, H., T. Wang, L. Naumovski, C. D. Lopez, and R. K. Brachmann. 2002. Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites. Oncogene 21:7901-7911.
67. Rampalli, S., L. Pavithra, A. Bhatt, T. K. Kundu, and S. Chattopadhyay. 2005. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex. Mol. Cell. Biol. 25:8415-8429.
68. Robyr, D., A. Gegonne, A. P. Wolffe, and W. Wahli. 2000. Determinants of vitellogenin B1 promoter architecture. HNF3 and estrogen responsive transcription within chromatin. J. Biol. Chem. 275:28291-28300.
69. Romero-Ramirez, L., H. Cao, D. Nelson, E. Hammond, A. H. Lee, H. Yoshida, K. Mori, L. H. Glimcher, N. C. Denko, A. J. Giaccia, Q. T. Le, and A. C. Koong. 2004. XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res. 64:5943-5947.
70. Sasaki, Y., S. Ishida, I. Morimoto, T. Yamashita, T. Kojima, C. Kihara, T. Tanaka, K. Imai, Y. Nakamura, and T. Tokino. 2002. The p53 family member genes are involved in the Notch signal pathway. J. Biol. Chem. 277:719-724.
71. Sengupta, S., and C. C. Harris. 2005. p53: traffic cop at the crossroads of DNA repair and recombination. Nat. Rev. Mol. Cell Biol. 6:44-55.
72. Shan, B., J. Xu, Y. Zhuo, C. A. Morris, and G. F. Morris. 2003. Induction of p53-dependent activation of the human proliferating cell nuclear antigen gene in chromatin by ionizing radiation. J. Biol. Chem. 278:44009-44017.
73. Shivji, K. K., M. K. Kenny, and R. D. Wood. 1992. Proliferating cell nuclear antigen is required for DNA excision repair. Cell 69:367-374.
74. Tan, M., S. Li, M. Swaroop, K. Guan, L. W. Oberley, and Y. Sun. 1999. Transcriptional activation of the human glutathione peroxidase promoter by p53. J. Biol. Chem. 274:12061-12066.
75. Tsuchimochi, K., N. Yagishita, S. Yamasaki, T. Amano, Y. Kato, K. Kawahara, S. Aratani, H. Fujita, F. Ji, A. Sugiura, T. Izumi, A. Sugamiya, I. Maruyama, A. Fukamizu, S. Komiya, K. Nishioka, and T. Nakajima. 2005. Identification of a crucial site for synoviolin expression. Mol. Cell. Biol. 25:7344-7356.
76. Vaupel, P. 2004. Tumor microenvironmental physiology and its implications for radiation oncology. Semin. Radiat. Oncol. 14:198-206.
77. Walter, K., G. Warnecke, R. Bowater, W. Deppert, and E. Kim. 2005. Tumor suppressor p53 binds with high affinity to CTG · CAG trinucleotide repeats and induces topological alterations in mismatched duplexes. J. Biol. Chem. 280:42497-42507.
78. Wang, L., Q. Wu, P. Qiu, A. Mirza, M. McGuirk, P. Kirschmeier, J. R. Greene, Y. Wang, C. B. Pickett, and S. Liu. 2001. Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches. J. Biol. Chem. 276:43604-43610.
79. Watanabe, T., S. Inoue, H. Hiroi, A. Orimo, H. Kawashima, and M. Muramatsu. 1998. Isolation of estrogen-responsive genes with a CpG island library. Mol. Cell. Biol. 18:442-449.
80. Webb, P., G. N. Lopez, R. M. Uht, and P. J. Kushner. 1995. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol. Endocrinol. 9:443-456.
81. Wei, C. L., Q. Wu, V. B. Vega, K. P. Chiu, P. Ng, T. Zhang, A. Shahab, H. C. Yong, Y. Fu, Z. Weng, J. Liu, X. D. Zhao, J. L. Chew, Y. L. Lee, V. A. Kuznetsov, W. K. Sung, L. D. Miller, B. Lim, E. T. Liu, Q. Yu, H. H. Ng, and Y. Ruan. 2006. A global map of p53 transcription-factor binding sites in the human genome. Cell 124:207-219.
82. Weinmann, A. S., P. S. Yan, M. J. Oberley, T. H. Huang, and P. J. Farnham. 2002. Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev. 16:235-244.
83. Wilkinson, D. S., S. K. Ogden, S. A. Stratton, J. L. Piechan, T. T. Nguyen, G. A. Smulian, and M. C. Barton. 2005. A direct intersection between p53 and transforming growth factor β pathways targets chromatin modification and transcription repression of the α-fetoprotein gene. Mol. Cell. Biol. 25:1200-1212.
84. Wittschieben, J., M. K. Shivji, E. Lalani, M. A. Jacobs, F. Marini, P. J. Gearhart, I. Rosewell, G. Stamp, and R. D. Wood. 2000. Disruption of the developmentally regulated Rev31 gene causes embryonic lethality. Curr. Biol. 10:1217-1220.
85. Wittschieben, J. P., S. C. Reshmi, S. M. Gollin, and R. D. Wood. 2006. Loss of DNA polymerase zeta causes chromosomal instability in mammalian cells. Cancer Res. 66:134-142.
86. Wu, F., X. Lin, T. Okuda, and S. B. Howell. 2004. DNA polymerase zeta regulates cisplatin cytotoxicity, mutagenicity, and the rate of development of cisplatin resistance. Cancer Res. 64:8029-8035.
87. Yang, L., T. Guan, and L. Gerace. 1997. Integral membrane proteins of the nuclear envelope are dispersed throughout the endoplasmic reticulum during mitosis. J. Cell Biol. 137:1199-1210.